伴侶動物藥品市場規模、佔有率和成長分析（按寵物類型、藥物類別、分銷管道和地區分類）－2026-2033年產業預測

預計到 2024 年，伴侶動物藥品市場規模將達到 168.7 億美元，到 2025 年將達到 180.2 億美元，到 2033 年將達到 305 億美元，在預測期（2026-2033 年）內，複合年成長率為 6.8%。

全球伴侶動物藥品市場正經歷強勁成長，這主要得益於寵物飼養量的增加、寵物保健意識的提高以及獸醫學的進步。隨著越來越多的家庭飼養寵物，對犬貓等動物的藥物和治療方法需求也日益成長。市場的主要促進因素包括預防性護理（包括疫苗接種和寄生蟲防治）的普及以及慢性病治療方案的多樣化。藥物傳遞方式和製劑的創新，例如調味片和外用藥物，提高了給藥的便利性。隨著寵物飼主越來越重視寵物的健康，伴侶動物藥品市場預計將持續成長，為製藥公司和獸醫在這個蓬勃發展的領域帶來巨大的機會。

伴侶動物藥品市場促進因素

受獸醫學進步的推動，伴侶動物藥品市場正經歷顯著成長。這些創新包括更有效的診斷方法、治療方法和藥物的研發，大大豐富了可供選擇的治療方案。疾病管理策略的改進和治療效果的提升也是推動這一趨勢的關鍵因素。隨著獸醫和寵物飼主逐漸認知到先進醫療方案的益處，對專用於伴侶動物的先進藥物的需求也不斷成長。獸醫學的全面進步進一步鞏固了高品質藥物在拓展市場和促進動物健康方面的重要性。

伴侶動物醫藥市場限制因素

伴侶動物藥品市場面臨巨大的挑戰，這主要是由於動物醫藥和治療帶來的經濟負擔。高昂的費用使得飼主難以重視寵物的健康，導致他們延後必要的醫療照護。這種經濟障礙在低收入社區和預算有限的飼主中尤為突出，他們可能難以負擔昂貴的寵物醫療保健費用。因此，伴侶動物藥品的高昂價格阻礙了市場普及，並最終威脅到寵物的健康和福祉。

伴侶動物醫藥市場趨勢

伴侶動物醫療市場正呈現出顯著的數位化健康解決方案整合趨勢，這正在革新獸醫護理。穿戴式裝置和行動應用程式的普及使飼主能夠遠端監測寵物的健康狀況，從而加強預防性護理並及早發現潛在問題。遠距醫療服務日益普及，促進了飼主與獸醫之間的即時溝通，並改善了處方箋和治療方案的管理。這種向技術主導醫療保健的轉變不僅簡化了獸醫護理流程，也賦予了飼主更多自主權，並反映出市場對全面便捷的寵物護理解決方案日益成長的重視。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管分析
• 專利分析

全球伴侶動物藥品市場規模（依寵物類型分類）及複合年成長率（2026-2033 年）

• 狗
• 貓
• 馬
• 其他

全球伴侶動物藥品市場規模（按藥物類別和複合年成長率分類）（2026-2033 年）

• 抗生素
• 抗發炎藥
• 治療犬心絲蟲的藥物
• 驅蟲藥
• 營養藥物
• 行為藥物
• 疫苗
• 其他

全球伴侶動物藥品市場規模（依通路分類）及複合年成長率（2026-2033 年）

• 獸醫院藥房
• 電子商務
• 零售藥房

全球伴侶動物藥品市場規模（按地區分類）及複合年成長率（2026-2033 年）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Zoetis（USA）
• Elanco Animal Health（USA）
• Virbac（France）
• Ceva Sante Animale（France）
• Boehringer Ingelheim（Germany）
• Merck Animal Health（USA）
• Bayer Animal Health（Germany）
• Kemin Industries（USA）
• Hester Biosciences（India）
• Vetoquinol（France）
• Dechra Pharmaceuticals（UK）
• IDEXX Laboratories（USA）
• Mars Petcare（USA）
• Nestle Purina Petcare（Switzerland）
• Hill's Pet Nutrition（USA）
• Boehringer Ingelheim Vetmedica（Germany）
• MSD Animal Health（USA）
• Bayer HealthCare Animal Health（Germany）
• Virbac Animal Health（France）
• Ceva Animal Health（France）

結論與建議

Companion Animal Drugs Market size was valued at USD 16.87 Billion in 2024 and is poised to grow from USD 18.02 Billion in 2025 to USD 30.5 Billion by 2033, growing at a CAGR of 6.8% during the forecast period (2026-2033).

The global companion animal drugs market is witnessing robust expansion, fueled by increasing pet ownership, heightened awareness of pet healthcare, and advancements in veterinary pharmaceuticals. As more households embrace pet companionship, there is a rising demand for various medications and treatments for animals such as dogs and cats. Key market drivers include a shift toward preventive care, encompassing vaccinations and parasite management, along with a growing array of therapeutic options for chronic conditions. Innovations in drug delivery methods and formulations, such as flavored tablets and topical treatments, are improving administration ease. With pet owners prioritizing their animals' health, the companion animal drugs market is set for continued growth, presenting significant opportunities for pharmaceutical companies and veterinarians in this thriving sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Companion Animal Drugs market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Companion Animal Drugs Market Segments Analysis

Global Companion Animal Drugs Market is segmented by Companion Animals, Drug Class, Distribution Channel and region. Based on Companion Animals, the market is segmented into Dogs, Cats, Horses and Others. Based on Drug Class, the market is segmented into Antibiotics, Anti-inflammatory, Heart Worm Drugs,parasiticides, Nutritional Drugs, Behavioral Drugs, Vaccines and Others. Based on Distribution Channel, the market is segmented into Veterinary Pharmacies, E-commerce and Retail Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Companion Animal Drugs Market

The companion animal drugs market is experiencing significant growth, driven by advancements in veterinary medicine. These innovations encompass the creation of more effective diagnostics, treatments, and pharmaceuticals, which have greatly enriched the variety of available therapeutic options. Enhanced disease management strategies and increased treatment efficacy are also pivotal developments contributing to this trend. As veterinarians and pet owners recognize the benefits of improved medical solutions, there is a heightened demand for sophisticated medications tailored to companion animals. This overall progress in veterinary care is further solidifying the market's expansion and the importance of high-quality pharmaceuticals in promoting animal health.

Restraints in the Companion Animal Drugs Market

The Companion Animal Drugs market is encountering significant challenges due to the financial strain associated with veterinary medicines and treatments. High costs can deter pet owners from prioritizing their animals' health, leading to delays in seeking necessary medical care. This financial barrier is particularly pronounced among pet owners in low-income areas or those operating on tight budgets, as they may struggle to afford these expensive healthcare options for their pets. As a result, the substantial expense associated with companion animal medications can impede widespread market adoption and ultimately compromise the health and well-being of pets.

Market Trends of the Companion Animal Drugs Market

The Companion Animal Drugs market is experiencing a notable trend towards the integration of digital health solutions, which are revolutionizing veterinary care. The rise of wearable devices and mobile applications allows pet owners to remotely monitor their animals' health, enhancing proactive care and early detection of potential issues. Telehealth services are becoming increasingly popular, facilitating real-time communication between pet owners and veterinarians, thus improving the management of prescriptions and treatment plans. This shift towards technology-driven healthcare not only streamlines the veterinary experience but also empowers pet owners, reflecting a growing emphasis on holistic and accessible pet care solutions in the marketplace.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Patent Analysis

Global Companion Animal Drugs Market Size by Companion Animals & CAGR (2026-2033)

• Market Overview
• Dogs
• Cats
• Horses
• Others

Global Companion Animal Drugs Market Size by Drug Class & CAGR (2026-2033)

• Market Overview
• Antibiotics
• Anti-inflammatory
• Heart Worm Drugs
• Parasiticides
• Nutritional Drugs
• Behavioral Drugs
• Vaccines
• Others

Global Companion Animal Drugs Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Veterinary Pharmacies
• E-commerce
• Retail Pharmacies

Global Companion Animal Drugs Market Size & CAGR (2026-2033)

• North America (Companion Animals, Drug Class, Distribution Channel)
  • US
  • Canada
• Europe (Companion Animals, Drug Class, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Companion Animals, Drug Class, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Companion Animals, Drug Class, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Companion Animals, Drug Class, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer Animal Health (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kemin Industries (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hester Biosciences (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dechra Pharmaceuticals (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDEXX Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mars Petcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nestle Purina Petcare (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hill's Pet Nutrition (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim Vetmedica (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MSD Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer HealthCare Animal Health (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac Animal Health (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Animal Health (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations